Tumor suppressor protein p53 and inhibitor of apoptosis proteins in colorectal cancer — a promising signaling network for therapeutic interventions

Despite recent advances in the treatment of colorectal cancer (CRC), patient’s individual response and clinical follow-up vary considerably with tumor intrinsic factors to contribute to an enhanced malignancy and therapy
Despite recent advances in the treatment of colorectal cancer (CRC), patient’s individual response and clinical follow-up vary considerably with tumor intrinsic factors to contribute to an enhanced malignancy and therapy resistance. Among these markers, upregulation of members of the inhibitor of apoptosis protein (IAP) family effects on tumorigenesis and radiation- and chemo-resistance by multiple pathways, covering a hampered induction of apoptosis/autophagy, regulation of cell cycle progression and DNA damage response. These mechanisms are tightly controlled by the tumor suppressor p53 and thus transcriptional and post-translational regulation of IAPs by p53 is expected to occur in malignant cells. By this, cellular IAP1/2, X-linked IAP, Survivin, BRUCE and LIVIN expression/activity, as well as their intracellular localization is controlled by p53 in a direct or indirect manner via modulating a multitude of mechanisms. These cover, among others, transcriptional repression and the signal transducer and activator of transcription (STAT)3 pathway. In addition, p53 mutations contribute to deregulated IAP expression and resistance to therapy. This review aims at highlighting the mechanistic and clinical importance of IAP regulation by p53 in CRC and describing potential therapeutic strategies based on this interrelationship.
show moreshow less

Download full text files

Export metadata

  • Export Bibtex
  • Export RIS
Metadaten
Author:Ömer Güllülü, Stephanie Hehlgans, Claus Rödel, Emmanouil Fokas, Franz Rödel
URN:urn:nbn:de:hebis:30:3-617707
DOI:http://dx.doi.org/10.3390/cancers13040624
ISSN:2072-6694
Parent Title (English):Cancers
Publisher:MDPI
Place of publication:Basel
Document Type:Article
Language:English
Date of Publication (online):2021/02/04
Date of first Publication:2021/02/04
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2021/07/15
Tag:BRUCE; LIVIN; Survivin; TP53; XIAP; cIAP1/2 ; colorectal carcinoma; inhibitor of apoptosis protein family
Volume:13
Issue:4, art. 624
Pagenumber:22
First Page:2
Last Page:22
HeBIS PPN:484966138
Institutes:Medizin
Dewey Decimal Classification:610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Open-Access-Publikationsfonds:Medizin
Licence (German):License LogoCreative Commons - Namensnennung 4.0

$Rev: 11761 $